Insider trades
Jurgi Camblong, CEO of SOPHiA Genetics SOPH, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $879K. The latest trade was on 06/26.
Jurgi Camblong
CEO
- Company
- SOPHiA Genetics SOPH
- First filing
- 25/01/24
- Trades
- 23 trades
- Buys / sales
- 0 / 17
- 12-month net buying
- −$879K
- Last trade
- 06/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
SOPH | Open-market sale10b5-1 plan | 06/25–06/26 | 06/29 | 51,442 sh3 trades | $5.80avg. | $298,234.87 | −1.4% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/10 | 06/11 | 8,500 sh | $5.24 | $44,540 | −0.2% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/19 | 05/20 | 4,486 sh | $4.60 | $20,635.6 | −0.1% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/11 | 05/12 | 8,500 sh | $5.09 | $43,265 | −0.2% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 04/20 | 04/21 | 4,486 sh | $5.21 | $23,372.06 | −0.1% |
SOPH | Open-market sale10b5-1 plan | 04/14–04/15 | 04/16 | 60,602 sh2 trades | $4.97avg. | $301,284.84 | −1.6% |
SOPH | Open-market sale10b5-1 plan | 04/10–04/13 | 04/14 | 16,631 sh3 trades | $4.73avg. | $78,674.28 | −0.4% |
SOPH | Open-market sale10b5-1 plan | 04/08–04/09 | 04/10 | 4,750 sh2 trades | $4.80avg. | $22,795 | −0.1% |
SOPH | Open-market sale10b5-1 plan | 04/06–04/07 | 04/08 | 5,100 sh2 trades | $4.85avg. | $24,760 | −0.1% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 03/19 | 03/20 | 4,486 sh | $4.77 | $21,398.22 | −0.1% |